IDIS

What IDIS does

IDIS is a public biomedical research foundation (Fundación Pública Galega) headquartered within the Hospital Clínico Universitario de Santiago de Compostela complex in Galicia, Spain. It coordinates more than 60 research groups across seven strategic areas — oncology, genetics and systems biology, endocrinology/nutrition/metabolism, neurosciences, platforms and methodology, cardiovascular, and infectology/inflammation/vaccines — and provides translational research services, training programs, and shared technological platforms including a biobank and clinical research management systems. The institute is governed through FIDIS, its management foundation, under María Gómez-Reino, with scientific direction held by Mª Luz Couce Pico and area leadership including Rafael López López (oncology), Ángel Carracedo Álvarez (genetics), and Federico Martinón Torres (infectology).

The institute operates through a multi-channel engagement model encompassing competitive grant pursuit, philanthropic fundraising via FIDIS, technology transfer, and spin-off creation. Its core service offerings include a Technology Portfolio (Oferta Tecnológica), Software and Apps, Licensed Technologies, spin-off companies (Nasasbiotech with the M-Trap tumor cell capture device; DIVERSA Technologies), and the Código Rojo AI-medical-education platform. Revenue derives primarily from competitive research grants (ISCIII, European Commission, private foundations) and competitive staff contracts — 2026 fund attraction exceeded 50.9 million euros — with no direct product commercialization. Customers are not commercial buyers but rather institutional partners: Hospital Clínico Universitario de Santiago de Compostela (primary clinical host), Servizo Galego de Saúde (SERGAS), Universidade de Santiago de Compostela (USC), Instituto de Salud Carlos III (ISCIII), and ACIS, plus alignment with the European Open Science Cloud.

The go-to-market motion is community-led: IDIS engages the scientific community, healthcare professionals, and broader society through collaborative research, training, scientific seminars (IDIS Wednesdays), public outreach via the UCC+i unit, and multi-channel digital presence including a multilingual website and active profiles on LinkedIn, X, Facebook, Instagram, and YouTube. Distribution of research outputs occurs through open-access scientific publication, spin-off commercialization, and licensing of developed technologies. The institute holds HR Excellence in Research certification from the European Commission (since 2020) and ISCIII reaccreditation, signaling compliance with recognized European research quality standards.

Name

IDIS

Legal name

FUNDACIÓN PÚBLICA GALEGA INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA

Website

https://idisantiago.es

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

IDIS is a public Galician biomedical research foundation coordinating 60+ research groups across seven disease areas, delivering translational research, training, technology transfer, and spin-offs, funded primarily through competitive grants and institutional partnerships.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

Keywords

• Biomedical research
• Translational medicine
• Clinical research services
• Health research institute
• Medical technology transfer

Headquarters

HQ city

Santiago De Compostela

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Competitive Research Grants: Funding from national and international competitive calls including ISCIII, European Commission, and private foundations for research projects
2. Donations and Philanthropy: Individual and organizational donations managed through FIDIS foundation with tax deduction benefits under Spanish Law 49/2002
3. Competitive Staff Contracts: Nearly 10 million euros from competitive staff contracts supporting research personnel

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

IDIS is a public health research institute that conducts translational biomedical research across seven strategic areas—oncology, genetics and genomics, cardiovascular, neurosciences, endocrinology, infectious diseases, and methodological/platform research—coordinating more than 60 research groups affiliated with Hospital Clínico Universitario de Santiago and the Universidade de Santiago de Compostela. Beyond performing research, it operates shared core platforms (biobank, clinical trials management) and runs a technology-transfer program that licenses out medical devices, software applications, and spin-off companies developed from its research pipeline.

Product overview

IDIS is a health research institute that functions as a platform for translational biomedical research, offering technology transfer services, software applications, licensed technologies, and spin-off companies. The organization operates through multiple interconnected services: technology offerings (Oferta tecnológica) for commercialization, software and apps development, licensed technologies, and spin-off companies. Key offerings include research platforms, diagnostic devices like M-Trap for tumor cell capture, and the Código Rojo medical education platform. The institute provides research infrastructure, laboratory management, clinical research services, and training programs, functioning as a comprehensive research ecosystem rather than a single unified product.

Differentiator

Problem solved

Functional benefit

Named customers1 record

Segments2 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Five partnerships are on record, tiered core and strategic.

• Servizo Galego de Saúde (SERGAS)coreStrategic or Co-development PartnerCore institutional partnership providing clinical research infrastructure through Hospital Clínico Universitario de Santiago de Compostela. SERGAS is the Galician Health Service that enables translation of research into clinical practice.
• Universidade de Santiago de Compostela (USC)coreStrategic or Co-development PartnerAcademic partner providing research excellence and training through university faculty and research groups integrated into IDIS.
• Instituto de Salud Carlos III (ISCIII)coreStrategic or Co-development PartnerNational health research institute providing accreditation and funding for health research institutes across Spain. IDIS received reaccreditation from ISCIII.
• Axencia de Coñecemento en Saúde (ACIS)coreStrategic or Co-development PartnerGalician Health Knowledge Agency that coordinates health innovation and research programs including European projects like TITTAN.
• European Open Science Cloud (EOSC)strategicTechnology or IntegrationIDIS open science policy aligns with EOSC principles for Findable, Accessible, Interoperable and Reusable (FAIR) data publication in recognized open repositories.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• IBIMA - Instituto de Investigación Biomédica de Málaga: ISCIII-accredited Spanish health research institute integrating hospital and university research across multiple therapeutic areas; structurally and operationally comparable to IDIS in governance, funding model, and translational focus.
• IBSAL - Instituto de Investigación Biomédica de Salamanca: ISCIII-accredited biomedical research institute in Salamanca covering oncology, cardiovascular, neurosciences and other areas with a similar hospital-university foundation model to IDIS.
• IDIVAL - Instituto de Investigación Sanitaria Valdecilla: ISCIII-accredited health research institute linked to Hospital Universitario Marqués de Valdecilla, with comparable translational research scope and competitive grant funding profile to IDIS.
• IIS La Fe - Instituto de Investigación Sanitaria La Fe: Large ISCIII-accredited Spanish health research institute based at Hospital La Fe in Valencia, operating multiple research areas and clinical platforms analogous to IDIS, but at a larger scale.
• IMIM - Institut Hospital del Mar d'Investigacions Mèdiques: Barcelona-based biomedical research institute linked to Hospital del Mar; ISCIII-accredited and operating a comparable translational research, clinical trials, and competitive-grant funding model.

Broad incumbents

• IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer: Larger, internationally prominent Barcelona-based biomedical research institute affiliated with Hospital Clínic; operates the same translational research and clinical trials model as IDIS but with significantly greater funding scale and global visibility.
• VHIO - Vall d'Hebron Institut d'Oncologia: Leading oncology-focused research center at Vall d'Hebron Barcelona Hospital Campus; overlaps with IDIS' oncology area but operates at larger scale and with deeper industry partnerships.
• CNIO - Centro Nacional de Investigaciones Oncológicas: Spain's national cancer research centre, a much larger publicly funded institution with overlapping oncology research scope, broader international profile, and substantial competitive grant capture.
• IRB Barcelona - Institute for Research in Biomedicine: Well-established Barcelona-based biomedical research centre with comparable multi-area basic and translational research structure; competes for overlapping EU and competitive grants and scientific talent.

Regional players

• IIS Aragón - Instituto de Investigación Sanitaria Aragón: ISCIII-accredited regional health research institute in Aragón with a similar hospital-university foundation structure, but operating in a different Spanish region without direct overlap in catchment area.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/IDIS_research
• YouTubeyoutube.com/channel/UCf8DuywfO-8azzAbEbzFhqQ
• Facebookes-es.facebook.com/IDIS.Research
• LinkedInlinkedin.com/company/idisantiago
• Instagraminstagram.com/idis_research

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDIS